MDXG Competitors & Alternatives
Compare MiMedx Group Inc with similar stocks in the same industry
Biotechnology
MDXG
Main Stock$3.73
Tradestie Score
64
Market Cap
$1.01B
P/E Ratio
18.4
Revenue Growth
-0.3%
Analyst Upside
+74.3%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SVRA
Savara Inc.
|
$5.78
|
$611.84M | - | 66 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 57 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$3.15
|
$552.46M | - | 57 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$12.63
|
$540.97M | - | 54 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$13.00
|
$529.35M | 6.3 | 64 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.16
|
$512.39M | - | 57 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$35.61
|
$505.12M | 1.9 | 64 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$92.91
|
$492.21M | - | 53 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$41.95
|
$474.20M | 26.8 | 59 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$7.41
|
$468.01M | - | 58 | Compare |
More MDXG Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 3841)
227 stocks in this industry